Suvretta Capital Management, Llc - Nov 7, 2025 SCHEDULE 13D/A Report for Benitec Biopharma Inc. Common Stock, par value $0.0001 (BNTC)

Filing Manager
Suvretta Capital Management, Llc
Reporting Manager
SUVRETTA CAPITAL MANAGEMENT, LLC
Security
Benitec Biopharma Inc. Common Stock, par value $0.0001
Symbol
BNTC
Shares outstanding
40.3M shares
Disclosed Ownership
17.8M shares
Ownership
44.1%
Form type
SCHEDULE 13D/A
Date filed
11/10/2025, 09:53 PM
Date of event
Nov 7, 2025
Previous filing
Mar 28, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SUVRETTA CAPITAL MANAGEMENT, LLC 44.1% 17.8M 0 17.8M /s/ Andrew Nathanson Andrew Nathanson, General Counsel and Chief Compliance Officer 0001569064
Averill Master Fund, Ltd. 37.8% 15.2M 0 15.2M /s/ Andrew Nathanson Andrew Nathanson, Authorized Signatory 0001939329
Averill Madison Master Fund, Ltd. 6.3% 2.52M 0 2.52M /s/ Andrew Nathanson Andrew Nathanson, Authorized Signatory 0002021243
Aaron Cowen 44.1% 17.8M 0 17.8M /s/ Aaron Cowen Aaron Cowen